Skip to main content
Premium Trial:

Request an Annual Quote

David Budd

Epistem has appointed David Budd as CEO and a director of the company. He will join Epistem by the middle of April 2016. Budd joins Epistem from Leica Biosystems Amsterdam where he served as general manager. Previously, he served as commercial director at Leica Biosystems Newcastle. Prior to his work at Leica systems, he served as director of marketing at Siemens Healthcare Diagnostics, business unit leader at Bayer Diagnostics, and Sales Manager at Visible Genetics.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.